(S)-4-benzyl-3-((4-methylcyclohexyl)methyl)-1-(4-((S)-2-propyl-4,5-dihydro-1H-imidazol-4-yl)butyl)imidazolidine-2-thione

ID: ALA4094612

PubChem CID: 137656123

Max Phase: Preclinical

Molecular Formula: C28H44N4S

Molecular Weight: 468.76

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCC1=N[C@@H](CCCCN2C[C@H](Cc3ccccc3)N(CC3CCC(C)CC3)C2=S)CN1

Standard InChI:  InChI=1S/C28H44N4S/c1-3-9-27-29-19-25(30-27)12-7-8-17-31-21-26(18-23-10-5-4-6-11-23)32(28(31)33)20-24-15-13-22(2)14-16-24/h4-6,10-11,22,24-26H,3,7-9,12-21H2,1-2H3,(H,29,30)/t22?,24?,25-,26-/m0/s1

Standard InChI Key:  VXFUTSSNPDEHHM-SDAFTYILSA-N

Molfile:  

     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
   13.4975  -23.6601    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.1321  -24.1749    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8190  -23.7319    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.6078  -22.9398    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7925  -22.8993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0877  -24.9909    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   15.5812  -24.0265    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2894  -23.6193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9946  -24.0324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7009  -23.6286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7066  -22.8111    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9998  -22.3990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2873  -22.8045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4166  -22.4064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1217  -22.3044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8283  -21.5417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3432  -20.9079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0504  -20.1458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2424  -20.0180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7279  -20.6583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0235  -21.4180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7077  -23.8699    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1311  -23.2908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3413  -23.5007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7647  -22.9216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9749  -23.1314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3422  -22.6203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6559  -23.0640    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.8657  -23.8538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6817  -23.8982    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.3502  -24.4878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5433  -24.3583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0277  -24.9924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  1  1  0
  2  6  2  0
  3  7  1  0
  7  8  1  0
  8  9  1  0
  8 13  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 11 14  1  0
  4 15  1  6
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
  1 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 26 25  1  6
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  2  0
 30 26  1  0
 29 31  1  0
 31 32  1  0
 32 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4094612

    ---

Associated Targets(Human)

RORA Tchem Nuclear receptor ROR-alpha (562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rorb Nuclear receptor ROR-beta (15 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rorc Nuclear receptor ROR-gamma (89407 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 468.76Molecular Weight (Monoisotopic): 468.3287AlogP: 5.67#Rotatable Bonds: 11
Polar Surface Area: 30.87Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 10.47CX LogP: 6.15CX LogD: 3.82
Aromatic Rings: 1Heavy Atoms: 33QED Weighted: 0.33Np Likeness Score: -0.22

References

1. Nefzi A, Marconi GD, Ortiz MA, Davis JC, Piedrafita FJ..  (2017)  Synthesis of dihydroimidazole tethered imidazolinethiones and their activity as novel antagonists of the nuclear retinoic acid receptor-related orphan receptors (RORs).,  27  (7): [PMID:28242276] [10.1016/j.bmcl.2017.02.014]

Source